Sierra Oncology, Inc (SRRA) Covered Calls

You can sell covered calls on Sierra Oncology, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for SRRA (prices last updated Fri 11:55 AM ET):

Sierra Oncology, Inc (SRRA) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
0.56 0.00 0.56 0.56 70K -1.8 0.0B
Covered Calls For Sierra Oncology, Inc (SRRA)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Aug 16 2.5 0.00 0.56 0.0% 0.0%
Oct 18 2.5 0.00 0.56 0.0% 0.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Sierra Oncology, Inc., a clinical stage drug development company, researches, develops, and commercializes DNA Damage Response (DDR) therapeutics for the treatment of patients with cancer in the United States and internationally. The company's lead drug candidate is SRA737, an orally bioavailable small molecule inhibitor of Checkpoint kinase 1, which is in Phase 1 clinical trial to treat patients with advanced cancer. It also engages in developing SRA141, an orally bioavailable small molecule inhibitor of the cell division cycle 7 kinase that is in preclinical development stage. The company was formerly known as ProNAi Therapeutics, Inc. and changed its name to Sierra Oncology, Inc. in January 2017. Sierra Oncology, Inc. was founded in 2003 and is headquartered in Vancouver, Canada.